Trader Joe's continues Tennessee expansion, announces opening day for Murfreesboro store
The chain's shoppers in Rutherford County will gain a shorter commute when the Trader Joe's opens at 2305 Medical Center Parkway by Robert Rose Drive and near The Avenue Murfreesboro shopping center.
"Moments before doors open at 8 am, there will be a brief ribbon cutting," Rohde told The Daily News Journal. "Store Captain Jeff Carter and Trader Joe's Crew Members will be on hand to welcome customers to their new neighborhood store."
Trader Joe's is known for selling popular affordable products such as Dark Chocolate Peanut Butter Cups, Teeny Tiny Avocados, Everything But The Leftovers Seasoning Blend and Stir Fried Garlicky Cabbage.
The store will be a short drive from the Interstate 24 interchange with the busy Medical Center Parkway.
Trader Joe's coming to Murfreesboro: 'Neighborhood and location are a great fit'
Rohde told The Daily News Journal recently that Trader Joe's Murfreesboro store would offer a starting pay range of $14 to $17 per hour.
"As a neighborhood grocery store, Trader Joe's prides itself on hiring where our store is located," Rhode said. "The store has hired sixty-five new Crew Members from surrounding areas and transferred in others from neighboring Trader Joe's stores."
The new Murfreesboro Trader Joe's will donate 100% of products that go unsold but remain fit to enjoy to a range of non-profit, community-based organizations, seven days a week, in following the company's longstanding Neighborhood Shares Program, Rhode said.
Trader Joe's will be operating a 9,400-square-foot specialty grocery store built by Murfreesboro-based TDK Construction and Development.
'It's amazing': In-N-Out Burger plans to open restaurant in Murfreesboro
Prior to the signage appearing for the future Trader Joe's, Murfreesboro Mayor Shane McFarland confirmed to The Daily News Journal July 2024 that the construction project at Medical Center Parkway and Robert Rose Drive was for the popular grocery store chain.
"For months, we were saying specialty grocer, but this is where Trader Joe's is going to be located," McFarland said. "I think that's going to be a welcome addition to our community. A lot of people are really excited about it."
The new Trader Joe's in Murfreesboro will join six others in Tennessee.
The California-based Trader Joe's has two locations in Nashville and one in Franklin in Middle Tennessee; one each in Chattanooga and Knoxville in East Tennessee. and one in Germantown in West Tennessee, according to an internet search.
Murfreesboro to gain dining options: P.F. Chang's, Raising Cane's, Cava & Drake's plan restaurants at Clari Park development
Reach reporter Scott Broden with news tips or questions by emailing him at sbroden@dnj.com. To support his work with The Daily News Journal, sign up for a digital subscription.
This article originally appeared on Murfreesboro Daily News Journal: Trader Joe's to open first store in Murfreesboro, Tennessee
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 minutes ago
- Business Upturn
Aurobindo Pharma share: HSBC, Motilal Oswal, Nuvama maintain ‘Buy'; Avendus retains ‘Reduce' as brokerages assess US outlook and margin risks
Shares of Aurobindo Pharma have drawn mixed reactions from top brokerages following its recent earnings performance. While HSBC, Motilal Oswal, and Nuvama continue to maintain a 'Buy' rating, Avendus has retained a more cautious 'Reduce' stance, citing near-term margin and execution risks in the US segment. Motilal Oswal on Aurobindo Pharma share: Maintains 'Buy', TP cut to ₹1,300 Motilal Oswal Financial Services has maintained its 'Buy' rating on Aurobindo Pharma but lowered the target price to ₹1,300 from ₹1,365. The brokerage noted strong growth in the EU and ARV segments but flagged continued margin pressure as a drag on profitability. EBITDA margin guidance remains unchanged at 20–21% for FY26. Motilal is optimistic about the Lanett acquisition improving profitability and expects the company to file its first US biosimilar in FY26. Earnings estimates for FY26/FY27 were cut by 8%/7% due to pricing headwinds and startup costs at Pen-G and China units. Avendus on Aurobindo Pharma share: Maintains 'Reduce', TP cut to ₹1,145 Avendus has reiterated its 'Reduce' rating with a revised target price of ₹1,145, down from ₹1,220. The firm expects US sales (excluding gRevlimid) to grow at a 9% CAGR over FY25–27E, driven by recovery in injectables and oral solids. EU revenues are expected to grow at a 14% CAGR, aided by new launches and China/Vizag-based supplies. However, the brokerage expressed concerns over delays in monetizing complex assets such as biosimilars and LA injectables, which are now expected to contribute meaningfully only post-FY28. Avendus projects a 15% EPS CAGR (ex-gRevlimid and Pen-G) through FY27 and sees the Lanett acquisition turning EPS-neutral by FY27. EPS estimates have been revised down by 9%/7% for FY26/FY27 due to lower sales and margin risks. HSBC on Aurobindo Pharma share: Maintains 'Buy', TP cut to ₹1,255 HSBC continues to maintain a 'Buy' call on Aurobindo Pharma, cutting its target price to ₹1,255. The brokerage flagged a Q1 miss driven by weaker-than-expected gRevlimid sales, US channel destocking, and pricing pressure in the API business. It highlighted Europe as a bright spot in the company's portfolio. HSBC remains constructive on future margin support from new plant supplies (Pen-G, Vizag, China) and expects volume-led growth to sustain. The brokerage is also watching for closure on the Lanett portfolio acquisition, which could add to long-term growth momentum. Nuvama on Aurobindo Pharma share: Maintains 'Buy', TP reduced to ₹1,445 Nuvama Institutional Equities has also maintained its 'Buy' rating while trimming the target price slightly to ₹1,445 from ₹1,460. The firm highlighted that gross margins remained resilient despite a decline in gRevlimid contributions. Ex-gRevlimid EBITDA margins expanded ~100 bps YoY. Key near-term triggers include the ramp-up of Pen-G and China units, MIP implementation, closure of the Lanett acquisition, and new injectable filings. Nuvama has trimmed its FY27E EPS forecast by around 2%, factoring in near-term execution risks. With varying degrees of optimism, brokerages remain focused on Aurobindo's US trajectory, biosimilar launches, and integration of recent acquisitions as key determinants of its medium-term growth story. Disclaimer: The views and investment recommendations expressed in this article are those of the respective brokerages. These do not represent the views of Business Upturn and do not constitute investment advice. Investors are advised to consult their financial advisors before making any investment decisions. Ahmedabad Plane Crash Arunika Jain, a graduate in Mass Communication, brings a fresh perspective to the world of journalism. Arunika has a passion for writing finance and corporate news at You can write to her at [email protected]
Yahoo
6 minutes ago
- Yahoo
Columbia vs. Columbia: Oregon brand accuses university of trademark infringement
PORTLAND, Ore. () — In a new lawsuit, an Oregon sportswear company is alleging an East Coast university of the same name is misleading customers by selling similar merchandise. Columbia Sportswear filed a complaint against Columbia University on Wednesday, accusing the New York City institution of several offenses, including trademark infringement, unfair competition and breach of contract. Research detects 'unhealthy' noise levels in multiple Portland neighborhoods Court documents show the Portland-based apparel brand had already trademarked its name when it signed a contract with CU in 2023, agreeing that it would cooperate with the Ivy League school's efforts to register the identical name — as long as it mitigated any confusion among consumers. Plaintiffs claimed they agreed not to sue the university if it used the 'COLUMBIA' name only on apparel that featured insignia that represents the institution. But according to the sportswear giant, company employees in September 2024 noticed that several items on featured the name alone. Attorneys noted that both the company and the university use blue as their primary colors. They also noted that some merchandise showcases the logo of other activewear brands that are in the same market as Columbia, such as Champion and Nike. 'Though Columbia Sportswear and Nike are headquartered in the same State and are both highly reputable sporting apparel designers and have a generally friendly relationship, the two companies have never collaborated to jointly design, manufacture, market, or sell any product,' Attorneys Nika Aldrich and Jason Evans wrote. 'A consumer looking at the Infringing Merchandise would never know that, and, in fact, would reasonably be induced into believing the companies had.' Plaintiffs alleged the brand reached out to CU to discuss the terms of their agreement nearly a year ago, yet the university has continued to sell the apparel that sparked the lawsuit. KOIN 6 reached out to each party for a comment on the complaint, but both have declined to share a statement. Three new OYA staffers named in ongoing allegations of sex abuse at youth facility The Columbia trademark case follows a similar one that the in May. Earlier this year, the entertainment giant released a new animated series, 'Win Or Lose,' which centers on a softball team named the Pickles. Portland's team alleged that the branding from Disney+ has confused local sports fans. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
CNBC
an hour ago
- CNBC
Two Chinese nationals charged for illegally shipping Nvidia AI chips to China
Two Chinese nationals in California have been arrested and charged with the illegal shipment of tens of millions of dollars' worth of AI chips, the Department of Justice said Tuesday. Chuan Geng, 28, and Shiwei Yang, 28, exported the sensitive chips and other technology to China from October 2022 through July 2025 without obtaining the required licenses, the DOJ said, citing an affidavit filed with the complaint. The illicit shipments included Nvidia's H100 general processing units, according to the affidavit seen by Reuters. The H100 is amongst the U.S. chipmaker's most cutting-edge chips used in artificial intelligence allocations. The Department of Commerce has placed such chips under export controls since 2022 as part of broader efforts by the U.S. to restrict China's access to the most advanced semiconductor technology. This case demonstrates that smuggling is a "nonstarter," Nvidia told CNBC. "We primarily sell our products to well-known partners, including OEMs, who help us ensure that all sales comply with U.S. export control rules." "Even relatively small exporters and shipments are subject to thorough review and scrutiny, and any diverted products would have no service, support, or updates," the chipmaker added. Geng and Yang's California-based company, ALX Solutions, had been founded shortly after the U.S. chip controls first came into place. According to the DOJ, law enforcement searched ALX Solutions' office and seized the phones belonging to Geng and Yang, which revealed incriminating communications between the defendants, including communications about evading U.S. export laws by shipping the export-controlled chips to China through Malaysia. The review also showed that in December 2024, ALX Solutions made over 20 shipments from the U.S. to shipping and freight-forwarding companies in Singapore and Malaysia, which the DOJ said are commonly used as transshipment points to conceal illicit shipments to China. ALX Solutions did not appear to have been paid by entities they purportedly exported goods to, instead receiving numerous payments from companies based in Hong Kong and China. The U.S. Department of Commerce's Bureau of Industry and Security and the FBI are continuing to investigate the matter. The smuggling of advanced microchips has become a growing concern in Washington. According to a report from the Financial Times last month, at least $1 billion worth of Nvidia's chips entered China after Donald Trump tightened chip export controls earlier this year. In response to the report, Nvidia had said that data centers built with smuggled chips were a "losing proposition" and that it does not support unauthorized products.
